The global PDX Model market is anticipated to grow at a CAGR of around 15.5% during the forecast period. The rising prevalence of cancer in major economies is the key reason driving the demand for PDX models. As per the estimates from the International Agency for Research on Cancer (IARC), in 2018, 17.0 million new […]
Tag Archives: Patient-Derived Xenograft/PDX Model Market
The global PDX Model market is anticipated to grow at a CAGR of around 15.5% during the forecast period. The rising prevalence of cancer in major economies is the key reason driving the demand for PDX models. As per the estimates from the International Agency for Research on Cancer (IARC), in 2018, 17.0 million new […]
The global PDX Model market is anticipated to grow at a CAGR of around 15.5% during the forecast period. The rising prevalence of cancer in major economies is the key reason driving the demand for PDX models. As per the estimates from the International Agency for Research on Cancer (IARC), in 2018, 17.0 million new […]
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible […]